FINWIRES · TerminalLIVE
FINWIRES

加拿大皇家银行表示,Sprouts Farmers Market第一季度业绩可能基本符合预期。

-- 加拿大皇家银行资本市场(RBC Capital Markets)周二发布报告称,Sprouts Farmers Market (SFM) 预计第一季度业绩将“符合预期”,并重申其2026年业绩预测,同店销售额趋势略有改善。 RBC表示,由于自2月中旬以来“交易数据”有所改善,该公司将第一季度同店销售额预期从此前预测的下降2%上调至下降1.5%,略高于市场普遍预期。该公司还表示,由于持续投资于定价和会员忠诚度计划,利润率受到一定影响,预计调整后每股收益将维持在1.69美元,与华尔街预期基本一致。 Sprouts Farmers Market计划于4月29日发布第一季度财务业绩。 该券商表示,预计该公司管理层将在业绩发布后重申其2026年业绩指引,并指出本季度迄今为止的趋势保持“稳定”,这应该有助于“保持”对第二季度两年业绩预测的“信心”。报告预测,第二季度同店销售额将同比下降2%至持平,与市场普遍预期基本一致。 加拿大皇家银行(RBC)表示,市场“主要关注点”预计将是4月份的同店销售额表现,因为这是衡量同店销售额在经历了去年同期较为严峻的基数后能否开始“加速增长”的关键指标。 加拿大皇家银行维持对Sprouts Farmers Market的“跑赢大盘”评级,目标价维持在114美元不变。

Price: $74.65, Change: $+0.30, Percent Change: +0.40%

Related Articles

Asia

Clinuvel Unlikely to Seek Scenesse's Vitiligo Approval Before Phase 3 Completion, Says Jefferies

Clinuvel Pharmaceuticals (ASX:CUV) is unlikely to seek regulatory approval for Scenesse in vitiligo until the Phase 3 CUV105 and CUV107 clinical trials are completed, according to a Friday Jefferies note.The company said on Friday that the European Medicines Agency (EMA) has proposed evaluating the company's Scenesse drug for the treatment of systemic vitiligo based on a "totality of evidence" regulatory approach.Jefferies said that the EMA's decision is a positive for the company because of the high unmet medical need for Vitiligo treatment.The investment firm has pushed back its revenue expectations from Scenesse in vitiligo, which is now expected to begin in the second half of fiscal 2029 rather than fiscal 2028.Jefferies kept a buy rating on Clinuvel and cut its price target to AU$39.20 from AU$40.50.

$ASX:CUV
Asia

ASX Preview: Australian Shares Set to Open Flat on Stalled US-Iran Talks; Origin Energy Reports Lower March Quarter Production

Australian shares are set to open flat on Monday, as oil prices climbed almost 2% following stalled US-Iran peace negotiations and restricted flows through the Strait of Hormuz, tightening global supply and pushing Brent crude above $107 a barrel.On April 25, the S&P 500 and the Nasdaq Composite rose 0.8% and 1.6%, respectively, while the Dow Jones Industrial Average fell 0.2%.In the macroeconomy, investors are eyeing the release of Australia's consumer price index report on Wednesday.In corporate news, Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.IperionX's (ASX:IPX) titanium powder production operations in Virginia, US, transitioned to an around-the-clock production schedule during the March quarter, advancing from commissioning to continuous operations, according to a Monday filing with the Australian bourse.Australia's benchmark index fell 0.1% or 6.9 points to close at 8,786.50 on April 24.

$^AXJO$ASX:IPX$ASX:ORG
Asia

Cobre Appoints Chief Financial Officer

Cobre (ASX:CBE) has appointed Kaveen Bachoo as chief financial officer, effective April 28, according to a Monday filing with the Australian bourse.Bachoo has over 20 years of finance leadership experience in the mining sector, including executive positions at Glencore.

$ASX:CBE